🔓 Unlock the full profile of Eric Fahs (Genentech), including verified contact details, financial insights, and professional associations.
See Eric Fahs Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: eri*****@gen******.com
Mobile: 66254*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Eric Fahs serves as the Co-Founder of gREDi, an R&D incubator within Genentech, located in San Francisco, California.
- Genentech, founded in 1976, is a pioneering biotechnology company that has significantly impacted the development of pharmaceuticals and biological products.
- Under Eric Fahs' leadership, gREDi focuses on fostering innovation and advancing research to enhance drug development processes.
- Genentech is publicly traded under the symbol DNA and has made notable contributions to the field of biopharmaceuticals.
- The company has faced challenges, including fluctuations in organizational growth, indicating a headcount decline of approximately 2% over the past two years.
- Genentech maintains a strong online presence, with resources available on platforms such as its official website, LinkedIn, Twitter, and Facebook.
- Genentech is well-regarded for its commitment to research, contributing to various therapeutic areas, thereby enhancing patient care globally.
- The collaborative environment fostered by Eric Fahs in gREDi encourages creative exploration, leading to breakthroughs in healthcare solutions.